NCT03704818View on ClinicalTrials.gov

Dapagliflozin Effects on Hypoglycemia

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 8, 2018

Primary Completion Date

June 30, 2021

Study Completion Date

November 30, 2021

Conditions
Type1 Diabetes Mellitus
Interventions
DRUG

Dapagliflozin 5mg

Dapagliflozin treatment taken daily for 4-weeks.

DRUG

Placebo Oral Tablet

Placebo treatment taken daily for 4-weeks.

Trial Locations (1)

92037

UC San Diego Altman Clinical & Translational Research Institute, La Jolla

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of California, San Diego

OTHER